Literature DB >> 22798021

Characterization of supersaturatable formulations for improved absorption of poorly soluble drugs.

Ping Gao1, Yi Shi.   

Abstract

With the increasing number of poorly water-soluble compounds in contemporary drug discovery pipelines, the concept of supersaturation as an effective formulation approach for enhancing bioavailability is gaining momentum. This is intended to design the formulation to yield significantly high intraluminal concentrations of the drug than the thermodynamic equilibrium solubility through achieving supersaturation and thus to enhance the intestinal absorption. The major challenges faced by scientists developing supersaturatable formulations include controlling the rate and degree of supersaturation with the application of polymeric precipitation inhibitor and maintenance of post-administration supersaturation. This review is intended to cover publications on this topic since April 2009. Scientific publications associated with characterization of supersaturatable systems and related preclinical and clinical pharmacokinetics (PK) studies are reviewed. Specifically, this review will address issues related to assessing the performance of supersaturatable systems including: (1) Diversified approaches for developing supersaturatable formulations, (2) meaningful in vitro test methods to evaluate supersaturatable formulations, and (3) in vivo PK study cases which have demonstrated direct relevance between the supersaturation state and the exposure observed in animal models and human subjects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22798021      PMCID: PMC3475868          DOI: 10.1208/s12248-012-9389-7

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  26 in total

1.  Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica.

Authors:  Michiel Van Speybroeck; Randy Mellaerts; Raf Mols; Thao Do Thi; Johan Adriaan Martens; Jan Van Humbeeck; Pieter Annaert; Guy Van den Mooter; Patrick Augustijns
Journal:  Eur J Pharm Sci       Date:  2010-09-17       Impact factor: 4.384

2.  Growth of itraconazole nanofibers in supersaturated simulated intestinal fluid.

Authors:  Randy Mellaerts; Alexander Aerts; Tom P Caremans; Jan Vermant; Guy Van den Mooter; Johan A Martens; Patrick Augustijns
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

3.  Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing.

Authors:  James C DiNunzio; Justin R Hughey; Chris Brough; Dave A Miller; Robert O Williams; James W McGinity
Journal:  Drug Dev Ind Pharm       Date:  2010-09       Impact factor: 3.225

Review 4.  Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility.

Authors:  Dallas B Warren; Hassan Benameur; Christopher J H Porter; Colin W Pouton
Journal:  J Drug Target       Date:  2010-10-26       Impact factor: 5.121

5.  IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution/permeation system.

Authors:  Philipp Buch; Peter Langguth; Makoto Kataoka; Shinji Yamashita
Journal:  J Pharm Sci       Date:  2009-06       Impact factor: 3.534

6.  Excipient-mediated supersaturation stabilization in human intestinal fluids.

Authors:  Jan Bevernage; Thomas Forier; Joachim Brouwers; Jan Tack; Pieter Annaert; Patrick Augustijns
Journal:  Mol Pharm       Date:  2011-02-22       Impact factor: 4.939

7.  Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.

Authors:  Indrajit Ghosh; Sonali Bose; Radha Vippagunta; Ferris Harmon
Journal:  Int J Pharm       Date:  2011-03-01       Impact factor: 5.875

8.  Understanding the behavior of amorphous pharmaceutical systems during dissolution.

Authors:  David E Alonzo; Geoff G Z Zhang; Deliang Zhou; Yi Gao; Lynne S Taylor
Journal:  Pharm Res       Date:  2010-02-12       Impact factor: 4.200

9.  Highly supersaturated solutions from dissolution of amorphous itraconazole microparticles at pH 6.8.

Authors:  Michal E Matteucci; Joseph C Paguio; Maria A Miller; Robert O Williams; Keith P Johnston
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

10.  Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu.

Authors:  William Curatolo; James A Nightingale; Scott M Herbig
Journal:  Pharm Res       Date:  2009-03-10       Impact factor: 4.200

View more
  22 in total

Review 1.  Haste Makes Waste: The Interplay Between Dissolution and Precipitation of Supersaturating Formulations.

Authors:  Dajun D Sun; Ping I Lee
Journal:  AAPS J       Date:  2015-09-03       Impact factor: 4.009

2.  Role of Self-Association and Supersaturation in Oral Absorption of a Poorly Soluble Weakly Basic Drug.

Authors:  Ajit S Narang; Sherif Badawy; Qingmei Ye; Dhaval Patel; Maria Vincent; Krishnaswamy Raghavan; Yande Huang; Aaron Yamniuk; Balvinder Vig; John Crison; George Derbin; Yan Xu; Antonio Ramirez; Michael Galella; Frank A Rinaldi
Journal:  Pharm Res       Date:  2015-02-28       Impact factor: 4.200

3.  Utility of Physiologically Based Pharmacokinetic Absorption Modeling to Predict the Impact of Salt-to-Base Conversion on Prasugrel HCl Product Bioequivalence in the Presence of Proton Pump Inhibitors.

Authors:  Jianghong Fan; Xinyuan Zhang; Liang Zhao
Journal:  AAPS J       Date:  2017-07-14       Impact factor: 4.009

4.  Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan.

Authors:  Naveen Chella; Bhaskar Daravath; Dinesh Kumar; Rama Rao Tadikonda
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

5.  Self-assembled structures formed during lipid digestion: characterization and implications for oral lipid-based drug delivery systems.

Authors:  Stephanie Phan; Stefan Salentinig; Clive A Prestidge; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

6.  Quantifying In Vivo Luminal Drug Solubilization -Supersaturation-Precipitation Profiles to Explain the Performance of Lipid Based Formulations.

Authors:  Yusuke Tanaka; Erin Tay; Tri-Hung Nguyen; Christopher J H Porter
Journal:  Pharm Res       Date:  2020-02-03       Impact factor: 4.200

Review 7.  Hot-Melt Extrusion: a Roadmap for Product Development.

Authors:  Marta F Simões; Rui M A Pinto; Sérgio Simões
Journal:  AAPS PharmSciTech       Date:  2021-06-17       Impact factor: 3.246

8.  Combined use of crystalline sodium salt and polymeric precipitation inhibitors to improve pharmacokinetic profile of ibuprofen through supersaturation.

Authors:  Jenna L Terebetski; John J Cummings; Scott E Fauty; Bozena Michniak-Kohn
Journal:  AAPS PharmSciTech       Date:  2014-06-12       Impact factor: 3.246

Review 9.  Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems.

Authors:  Heejun Park; Eun-Sol Ha; Min-Soo Kim
Journal:  Pharmaceutics       Date:  2020-04-16       Impact factor: 6.321

10.  The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane.

Authors:  Arik Dahan; Avital Beig; Viktoriya Ioffe-Dahan; Riad Agbaria; Jonathan M Miller
Journal:  AAPS J       Date:  2012-12-15       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.